Clinical Study
Platelets and Inflammatory Markers in Patients with Gastric Cancer
Table 1
The stage of gastric cancer.
| | Group tested |
| | Tumor stage (TNM classification) | I + II ( = 13) | 26% | | III ( = 18) | 36% | | IV ( = 19) | 38% |
| | Depth of tumor invasion | T1 ( = 4) | 11% | | T2 ( = 7) | 19% | | T3 ( = 15) | 40% | | T4 ( = 11) | 30% |
| | Lymph node metastases | N0 ( = 7) | 17% | | N1 ( = 4) | 9% | | N2 ( = 13) | 31% | | N3 ( = 18) | 43% |
| | Distant metastases | M0 ( = 9) | 47% | | M1 ( = 10) | 53% |
|
|
